性菌体pB23和美罗胺组合的协同作用对抗抗卡巴胺耐药的Acinetobacter baumannii
Jun Luo1,2, Min Liu1,2, Wen Ai1,2
1The First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Antimicrobial agents and chemotherapy
|May 14, 2024
概括
这项研究发现,将菌体pB23与美罗胺结合起来,可以有效地对抗抗卡巴胺耐药的Acinetobacter baumannii. 这种菌体-抗生素组合在体外和体内表现出协同效应,提供了一种对抗耐药细菌感染的有希望的策略.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药物发现 药物发现 药物发现
背景情况:
- 抗生素耐药性是一个日益增长的全球健康威胁,特别是由耐卡巴尼姆的Acinetobacter baumannii引起的感染.
- 迫切需要新的治疗策略来对抗多药耐药细菌感染.
- 菌体-抗生素联合疗法是一个有希望的方法来提高抗微生物药物的疗效.
研究的目的:
- 为了研究新分离的菌体pB23的协同抗菌作用,与梅罗相结合,对抗抗卡巴胺耐药的Acinetobacter baumannii.
- 评估这种组合在清除和预防生物膜方面的有效性.
- 评估菌素-抗生素组合的体外和体内协同活性.
主要方法:
- 一种新型细菌 (pB23) 的分离和表征,该细菌向耐卡巴尼姆的Acinetobacter baumannii.
- 在体外评估协同抗菌活性,生物膜抑制和使用各种菌体剂量的预防 (MOI 0.11,000).
- 在体内评估使用猪皮肤扩展剂和斑马鱼感染模型,以证明伤口愈合和感染清除的协同效应.
主要成果:
- 菌体pB23在静态条件下在体外表现出与美罗胺对抗抗卡巴胺耐药的Acinetobacter baumannii的协同抗菌作用.
- 该组合有效清除成熟的生物膜,并防止新的生物膜形成.
- 外体 (猪皮) 和体内 (斑马鱼) 模型证实了协同作用的细菌清除和伤口愈合效应.
- 潜在的机制包括美罗胺促进菌体增殖和恢复耐药菌株的敏感性.
结论:
- 菌体pB23和美罗胺的组合显示出显著的协同抗菌活性,对抗抗卡巴胺耐药的Acinetobacter baumannii.
- 这种菌体-抗生素组合策略在各种模型中有效地对抗生物膜和感染.
- 这种方法提供了一种新的治疗策略,用于治疗由耐卡巴因的Acinetobacter baumannii和其他多药耐药细菌引起的感染.
更多相关视频
05:57The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
Published on: July 2, 2013
13.4K
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
585
相关概念视频
01:27Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
01:30Lytic Cycle of Bacteriophages
70.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K